Phibro Animal Health Q4 and FY 2025 Results to be Released on August 27, Conference Call Scheduled for August 28

Phibro Animal Health Corporation (PAHC) will release Q4 and FY 2025 results on August 27, 2025, and host a conference call and webcast on August 28, 2025, at 9:00 AM Eastern Time. The webcast will be available on the company's investor relations website and a replay will be available approximately two hours after the conclusion of the live event.

Phibro Animal Health Corporation (PAHC) is set to release its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. The company will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time [1][2].

Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. The conference ID is 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event, accessible via the same link [1][2].

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company has been experiencing strong growth, with its stock climbing 76.4% in a year, outpacing the industry’s 4.9% growth and the S&P 500 Composite’s 16% gain [3]. Key factors driving this growth include robust sales recovery within the Mineral Nutrition and Performance Product arms, a 4% year-over-year growth in the Mineral Nutrition business, and a 28% year-over-year increase in Performance Products sales. The company's expanding Animal Health product portfolio, following the acquisition of certain medicated feed additive and water-soluble products from Zoetis Inc., is also contributing to its growth [3].

Phibro's strong fundamentals and global footprint, extending to high-growth regions such as Brazil, China, India, and Southeast Asia, have been positive drivers for the stock. The company's fiscal third-quarter operating profit of $33.4 million, up 67.8% year over year, and a low short-term-payable debt of $16 million compared to total cash and short-term investments of $70.4 million, indicate a strong financial position [3].

Investors are looking forward to the upcoming earnings release to assess the company's performance and growth prospects. The Zacks Consensus Estimate for Phibro's fiscal 2025 earnings per share (EPS) is $2.04, with a projected increase of 71.4% year over year [3]. Revenues for fiscal 2025 are projected to grow 25.7% to $1.28 billion, while the same for fiscal 2026 is expected to reach $1.41 billion, implying a 10.1% increase [3].

References:
[1] https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-to-host-webcast-and-conference-call-bsgq6e36fhp5.html
[2] https://www.marketscreener.com/news/phibro-animal-health-corporation-to-host-webcast-and-conference-call-on-fourth-quarter-and-fiscal-ye-ce7c51d2d181f22c
[3] https://www.nasdaq.com/articles/pahc-stock-764-year-whats-driving-rally